Company intelligence
HealthTree Foundation
Research Services
South Jordan, US
51–200 employees
3 public signals
About HealthTree Foundation
Find your best blood cancer treatment options and clinical trials. Find your twin and chat or find side-effect solutions.
Verified activity
Signals from HealthTree Foundation
3 published signals
Products & Services
HealthTree Foundation continues Jenny Ahlstrom's vision through a patient-centered platform designed to connect patients, clinicians, and researchers to accelerate progress.
Reported by HealthTree Foundation
Presence & Recognition
HealthTree Foundation is hosting a webinar with Dr. Farrukh Awan on navigating multi-physician and shared care teams to discuss communication, care transitions, and treatment plans.
Reported by HealthTree Foundation
Legal & Regulatory
HealthTree Foundation reported that on August 31, 2026, the FDA approved ropeginterferon alfa-2b-njft (Besremi) for the treatment of adults with essential thrombocythemia (ET).
Reported by HealthTree Foundation